Citius pharmaceuticals selected to receive best poster award at the international society for cell and gene therapy 2021 annual meeting

Cranford, n.j., may 25, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today announced that it has received the best poster award at the prestigious international society for cell and gene therapy (isct) 2021 annual meeting.
CTXR Ratings Summary
CTXR Quant Ranking